Cell free ACE2 RNA: A potential biomarker of COVID-19 severity

Despite the downward trend of COVID-19 pandemic and increased immunity of the general population, COVID-19 is still an elusive disease with risks due to emerging variants. Fast and reliable diagnosis of COVID-19 disease would allow better therapeutic interventions for patients at risk to develop more severe outcomes. Cell-free RNAs (cfRNAs) have been proven to be an effective biomarker in cancer and infectious diseases. It has been reported that cfRNAs are amplified in the bloodstream of these patients and at earlier stages of the disease, reflecting tissue damage.

Source: Respiratory Medicine - September 18, 2023 Category: Respiratory Medicine Authors: Nour Jalaleddine, Mellissa Gaudet, Andrea Mogas, Mahmood Hachim, Abiola Senok, Narjes Saheb Sharif-Askari, Bassam Mahboub, Rabih Halwani, Qutayba Hamid, Saba Al Heialy Tags: Short communication Source Type: research